Unite for Change: Transforming Cardiovascular Care for People Living with Multiple Interconnected Chronic Conditions

Unite for Change: Transforming Cardiovascular Care for People Living with Multiple Conditions

A unified global, patient-led report created collaboratively by 165 delegates across 34 countries, calling for urgent action and a clear roadmap to transform outcomes for people living with cardiovascular and interconnected conditions worldwide.

Cardiovascular disease (CVD) is no longer an isolated health challenge. It exists within a complex web of Multiple Interconnected Chronic Conditions (MICC), including stroke, diabetes, chronic kidney disease, liver disease, obesity, hypertension, as well as amyloidosis and complications following organ transplants. Today, millions of people worldwide are not only managing CVD but also coping with these interconnected conditions, which are often the underlying cause and together amplify health risks and complicate care.

The Global Heart Hub Unite Summit convened lived experience communities from across these connected conditions, alongside policymakers, clinicians and researchers, to tackle the urgent need for integrated, people-centred cardiovascular care.

Five Key Joint Policy Asks:

The Unite Report outlines Five Key Joint Policy Asks that provide a clear, structured roadmap for policymakers to address urgent challenges of uncoordinated siloed care models, structural barriers in care coordination, equity gaps and more.

1. Multidisciplinary care & navigation for people with lived experience

2. Scale up early detection & community-based screening programmes

3. Accelerate access to innovation & digital health solutions

4. Guarantee equity in cardiovascular & multimorbidity care

5. Prevention, empowerment & mental health integration for people with lived experience

These Five Asks align with the forthcoming European Cardiovascular Health Plan and global policy efforts, ensuring a structured, scalable and impactful approach to reform.

Read the Report

The Time to Act is Now

Global Heart Hub calls on policymakers, healthcare leaders and industry partners to move from discussion to implementation. These Five Key Joint Asks provide a clear, actionable roadmap to drive meaningful reform and improve outcomes for people living with cardiovascular and interconnected conditions. The opportunity to change the trajectory of cardiovascular health is now.

People with multiple interconnected conditions face many challenges because of the way health systems are organised. Most health systems are designed to cater for people with a single chronic condition.

Living with Multiple Interconnected Chronic Conditions (MICC) presents significant challenges, not only in terms of medical management but also in its impact on daily life, emotional well-being and access to care.

Addressing the complexities of managing connected conditions requires a fundamental shift towards integration, collaboration and people-centred care. Improving detection, diagnosis and care coordination can ensure more responsive systems and meaningful impact for people managing multiple conditions.

Transforming healthcare requires more than just dialogue; it demands collective action from policymakers, healthcare professionals, patient organisations, industry and academia. Each stakeholder has a vital role to play in bridging systemic gaps and ensuring that people centred solutions become a reality.

By championing the Five Key Joint Asks, we take the first critical step toward a future where every person living with interconnected conditions receives the care they deserve.

The world is waking up to the urgent need for systemic change.

Join us in our mission to drive real change by improving care coordination, early detection, access to innovation, equity and empowerment.

This Summit was made possible with support from: AstraZeneca, Boehringer Ingelheim, Daiichi Sankyo, Edwards Lifesciences, Fáilte Ireland, MSD, Novartis, Novo Nordisk, Roche and Servier.

This summit was made possible with support from: AstraZeneca, Boehringer Ingelheim, Daiichi Sankyo, Edwards Lifesciences, Fáilte Ireland, MSD, Novartis, Novo Nordisk, Roche and Servier.

Contact Us

info@globalhearthub.org

Useful Links

Cookie Policy